Litman Gregory Wealth Management LLC Abbott Laboratories Transaction History

Litman Gregory Wealth Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 27, 2021	SELL	$105.79 - $124.53 $56,597 - $66,623	-535 Closed	0 $0
Q1 2020 Apr 28, 2020	BUY	$62.82 - $91.86 $18,846 - $27,558	300 Added 127.66%	535 $42,000
Q4 2019 Jan 30, 2020	SELL	$78.51 - $87.4 $17,429 - $19,402	-222 Reduced 48.58%	235 $20,000
Q3 2019 Nov 06, 2019	SELL	$81.84 - $88.74 $18,168 - $19,700	-222 Reduced 32.7%	457 $38,000
Q2 2019 Jul 31, 2019	BUY	$72.88 - $85.0 $34,909 - $40,715	479 Added 239.5%	679 $57,000
Q1 2018 May 07, 2018	BUY	$56.27 - $63.62 $11,254 - $12,724	200 New	200 $12,000

3,189

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $197B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Litman Gregory Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Litman Gregory Wealth Management LLC with notifications on news.